These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28754073)

  • 1. TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas.
    Oliveira TF; Maués T; Ramundo MS; Figueiredo AMS; de Mello MFV; El-Jaick KB; Ferreira MLG; Ferreira AMR
    J Vet Diagn Invest; 2017 Nov; 29(6):865-868. PubMed ID: 28754073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGAM1 and TP53 mRNA levels in canine mammary carcinomas - Short communication.
    Maués T; Oliveira TF; El-Jaick KB; Figueiredo AMS; Ferreira MLG; Ferreira AMR
    Acta Vet Hung; 2021 Apr; 69(1):50-54. PubMed ID: 33844639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced canine BRCA2 expression levels in mammary gland tumors.
    Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
    BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.
    Sánchez-Céspedes R; Millan Y; Guil-Luna S; García-Macías J; Maniscalco L; Iussich S; De Maria R; M de Las Mulas J
    J Vet Diagn Invest; 2018 Jan; 30(1):155-160. PubMed ID: 29020879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
    Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
    Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
    Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
    Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
    Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
    Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles in canine mammary carcinomas of various grades of malignancy.
    Pawłowski KM; Maciejewski H; Dolka I; Mol JA; Motyl T; Król M
    BMC Vet Res; 2013 Apr; 9():78. PubMed ID: 23587192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The overexpression of Hsp90B1 is associated with tumorigenesis of canine mammary glands.
    Sunil Kumar BV; Bhardwaj R; Mahajan K; Kashyap N; Kumar A; Verma R
    Mol Cell Biochem; 2018 Mar; 440(1-2):23-31. PubMed ID: 28801701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression analysis of prohibitin mRNA in canine mammary tumors.
    Matsuyama S; Nakano Y; Nakamura M; Yamamoto R; Shimada T; Ohashi F; Kubo K
    J Vet Med Sci; 2015 Jan; 77(1):101-4. PubMed ID: 25312047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
    Eivani D; Mortazavi P
    Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.